Co-Producer
|
|
|
EDITOR'S NOTE: Big4Bio newsletters will not
be published on Monday, Jan 20th; they will
resume distribution on Tuesday, Jan 21st.
|
|
| *
- may be subscription-only |
|
|
- AstraZeneca: CALQUENCE (Acalabrutinib) Plus
Chemoimmunotherapy Approved in the US for Patients
With Previously Untreated Mantle Cell Lymphoma More
More*
- Avacta: Positive New Data From the AVA6000 Phase
1 Trial Demonstrating Clinically Meaningful Tumor
Shrinkage in Patients With Salivary Gland Cancers More
More
- Integral Molecular: Recognized as an Employer of
Choice by the City of Philadelphia More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
|
- Madrigal CEO
Touts 'Amazing' Sales Success of New MASH Drug, But
Stock Slumps More*
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Join Big4Bio CBO Dave Whelan in Munich for DxPx;
Save With a Special Discount Code! More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
|
|
|
Section
Sponsor:
|
|
|
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Philadelphia Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
|
|
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- OPPORTUNITY: Senior Director, Integrated Marketing
& Communications - Remote More
- OPPORTUNITY: Clinical Development Leader - New York,
NY More
- OPPORTUNITY: Sales Executive - Hybrid More
- OPPORTUNITY: Senior Director of Business Development
- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs - MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America - Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
